![Noriko Koizumi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Noriko Koizumi
Direktor/Vorstandsmitglied bei SEED CO.,LTD.
Aktive Positionen von Noriko Koizumi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SEED CO.,LTD. | Direktor/Vorstandsmitglied | 24.06.2022 | - |
Independent Dir/Board Member | 24.06.2022 | - | |
Doshisha University | Corporate Officer/Principal | 01.04.2010 | - |
Graduate School of Medicine Kyoto University | Corporate Officer/Principal | 01.04.2015 | - |
ActualEyes, Inc.
![]() ActualEyes, Inc. Packaged SoftwareTechnology Services ActualEyes, Inc. is a Japanese company that conducts research and development of products such as regenerative medicine for corneal endothelial disease. The company is based in Kyotanabe, Japan. The company's mission is to deliver the desired light to patients suffering from visual impairment and to ensure and promptly implement a new treatment society. The company was founded in 2018. The CEO is Iku Sugioka. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2018 | - |
Karriereverlauf von Noriko Koizumi
Ausbildung von Noriko Koizumi
Kyoto Prefectural University of Medicine | Undergraduate Degree |
Statistik
International
Japan | 5 |
2 |
Operativ
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 2 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SEED CO.,LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
ActualEyes, Inc.
![]() ActualEyes, Inc. Packaged SoftwareTechnology Services ActualEyes, Inc. is a Japanese company that conducts research and development of products such as regenerative medicine for corneal endothelial disease. The company is based in Kyotanabe, Japan. The company's mission is to deliver the desired light to patients suffering from visual impairment and to ensure and promptly implement a new treatment society. The company was founded in 2018. The CEO is Iku Sugioka. | Technology Services |
- Börse
- Insiders
- Noriko Koizumi
- Erfahrung